OCULAR THERAPEUTIX, INC (OCUL) › Shareholders' EquityOCULAR THERAPEUTIX, INC (OCUL) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.2011: -$32.73M2012: -$46.61M2013: -$59.47M2014: $58.70M2015: $89.59M2016: $52.01M2017: $26.15M2018: $35.88M2019: -$3.63M2020: $76.09M2021: $88.00M2022: $35.38M2023: $91.13M2024: $315.34M2025: $654.31M$654.31M2011Shareholders' Equity (USD)2025Fiscal YearShareholders' EquityChange YoY2025$654.31M+107.5%2024$315.34M+246.0%2023$91.13M+157.6%2022$35.38M-59.8%2021$88.00M+15.6%2020$76.09M+2196.3%2019-$3.63M-110.1%2018$35.88M+37.2%2017$26.15M-49.7%2016$52.01M-41.9%2015$89.59M+52.6%2014$58.70M+198.7%2013-$59.47M-27.6%2012-$46.61M-42.4%2011-$32.73M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share